Delivery Order SPE2DB20D2014-SPE2DB24FD08T

Award Date 9/20/24
Potential Completion Date 9/23/24
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ISENTRESS 400 MG TABLET 60S, a prescription medication. The contract has a firm fixed price of $2,537.88 and a period of performance ending on June 25, 2025. The contract is not set aside and was awarded on June 24, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ISENTRESS 400 MG TABLET 60S. The contract has a ceiling value of $4,345.82 and a performance period through May 1, 2025. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a global pharmaceutical support vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide ISENTRESS 400 MG TABLET 60S. The contract has a firm fixed price of $1,268.94 and a performance period ending on June 5, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999.00 held by AmerisourceBergen Drug Corp, which enables the company to supply a wide range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ISENTRESS 400 MG TABLET 60S, a prescription medication, with a ceiling value of $3,345.90 and a performance period ending on May 16, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,806.82, is for the delivery of ISENTRESS 400 MG TABLET 60S, a pharmaceutical product. The contract is a firm fixed price arrangement with a completion date of May 23, 2025. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of ISENTRESS 400 MG TABLET 60S. The contract has a firm fixed price of $2,980.82 and a period of performance ending on July 7, 2025. Amerisourcebergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and pharmaceutical products to federal agencies, with a particular focus on delivering a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a civilian agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide the medication ISENTRESS 400 MG TABLET 60S. The $1,840.85 firm fixed-price contract has a completion date of May 28, 2025. This contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical to supply a wide range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ISENTRESS 400 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $1,534.16. The contract is a firm fixed-price, non-set-aside award with a performance period through July 7, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,185.24 firm fixed-price contract is for the supply of ISENTRESS 400 MG Tablet 60s, a prescription drug. The contract has an ultimate completion date of September 3, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA to efficiently...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ISENTRESS 400 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $13,511.48 and a completion date of May 13, 2025. The contract is a Firm Fixed Price, non-set-aside award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FD08T
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of ISENTRESS 400 MG TABLET 60S, a pharmaceutical product. The contract is a firm-fixed price, delivery order with a ceiling value of $14,223.00 and a completion date of September 23, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities in support of military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 12/20/24, 9:27 AM